ECSP951392A - QUINOLIZINONE TYPE COMPOUNDS - Google Patents

QUINOLIZINONE TYPE COMPOUNDS

Info

Publication number
ECSP951392A
ECSP951392A ECSP951392A ECSP951392A EC SP951392 A ECSP951392 A EC SP951392A EC SP951392 A ECSP951392 A EC SP951392A EC SP951392 A ECSP951392 A EC SP951392A
Authority
EC
Ecuador
Prior art keywords
lower alkyl
formula
compounds
hydrogen
type compounds
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Daniel T Chu
Qun Li
Curt S Cooper
Anthony K L Fung
Cheuk M Lee
Jacob J Plattner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP951392 priority Critical patent/ECSP951392A/en
Publication of ECSP951392A publication Critical patent/ECSP951392A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona compuestos antibacterianos que tienen la formula **formula** y sus sales farmacéuticamente aceptables, esteres y amidas de los mismos, los ejemplos preferidos de los cuales incluyen aquellos compuestos en los que r1 es cicloalquilo de tres a ocho atomos de carbono o fenilo sustituido;r2 se selecciona del grupo que consiste de **formula** r3 es halogeno;r4 es hidrogeno, alquilo inferior, un cation farmacéuticamente aceptable o un grupo del profarmaco; r5 es hidrogeno, alquilo inferior, halo(alquilo inferior) o nr13r14;y, r6 es alquilo inferior, así como también composiciones farmacéuticas que contiene tales compuestos y el uso de los mismos en el tratamiento de las infecciones bacterianas.The present invention provides antibacterial compounds having the formula ** formula ** and their pharmaceutically acceptable salts, esters and amides thereof, preferred examples of which include those compounds in which r1 is cycloalkyl of three to eight carbon atoms or substituted phenyl, r2 is selected from the group consisting of ** formula ** r3 is halogen, r4 is hydrogen, lower alkyl, a pharmaceutically acceptable cation or a group of the prodrug; r5 is hydrogen, lower alkyl, halo (lower alkyl) or nr13r14; and, r6 is lower alkyl, as well as pharmaceutical compositions containing such compounds and their use in the treatment of bacterial infections.

ECSP951392 1995-02-24 1995-02-24 QUINOLIZINONE TYPE COMPOUNDS ECSP951392A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP951392 ECSP951392A (en) 1995-02-24 1995-02-24 QUINOLIZINONE TYPE COMPOUNDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP951392 ECSP951392A (en) 1995-02-24 1995-02-24 QUINOLIZINONE TYPE COMPOUNDS

Publications (1)

Publication Number Publication Date
ECSP951392A true ECSP951392A (en) 1996-01-15

Family

ID=42042037

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP951392 ECSP951392A (en) 1995-02-24 1995-02-24 QUINOLIZINONE TYPE COMPOUNDS

Country Status (1)

Country Link
EC (1) ECSP951392A (en)

Similar Documents

Publication Publication Date Title
ECSP034914A (en) "AZAINDOLS"
ES2126573T3 (en) DERIVATIVE OF PYRAZOLE (1,5-A) PIRIMIDINE AND ANTI-INFLAMMATORY AGENT CONTAINING THIS DERIVATIVE.
PA8489501A1 (en) CETOLID ANTIBIOTICS
MX9709416A (en) Quinolizinone type compounds.
NO953126D0 (en) N-alkyl-2-substituted ATP analogs
BRPI0413876A (en) thienopyridin-phenylacetamides and their derivatives useful as antiangiogenic agents
ATE217309T1 (en) QUINOLIZINONE TYPE COMPOUNDS
SV1999000188A (en) NEW ANTIBIOTICS MACROLIDES REF. PC10145 / 82804 / BB
PT1263730E (en) Amine derivatives for the treatment of apoptosis
NO20025641D0 (en) Substituted 1-aminoalkyl lactams and their use as muscarinic receptor antagonists
SV2002000504A (en) REPLACED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH REF.PC10760 / 20205 / BB
PL361282A1 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
DE60102171D1 (en) Ketolidantibiotika
BR9812239A (en) Compound, pharmaceutical formulation, use of the compound, processes for the treatment of disorders, for the treatment of disorders mediated by 5-hydroxytryptamine, and for the preparation of the compound
AR007108A1 (en) ANTI-TUMOR AND ANTIVIRAL RENTAL AGENTS, PROCEDURE FOR THEIR PREPARATION, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH AGENTS.
ES2103440T3 (en) NEW AMPHASES AND NAPHTHALENIC SULPHONAMIDES, PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
PA8471801A1 (en) HYGROMYCIN A DERIVATIVES
MXPA05010783A (en) Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues.
PT1167376E (en) MACROLIDOS ANTIBIOTICS
CR6503A (en) DERIVATIVES OF- 1-TRIFLUOROMETIL-4-HIDROXI-7-PIPERIDINIL-AMINOMETICLCROMANO
PA8471901A1 (en) 2 "-DESOXY HYGROMYCIN DERIVATIVES
SV2002000474A (en) HYGROMYCIN DERIVATIVES TO REF.PC11O32ABCZ / BB
AR019784A1 (en) HYGROMYCIN DERIVATIVES
ECSP993164A (en) NEW MACROLID ANTIBIOTICS
ECSP992943A (en) HYGROMYCIN A DERIVATIVES